Intragraft regulatory T cells in the modern era: what can high-dimensional methods tell us about pathways to allograft acceptance?
Replacement of diseased organs with transplanted healthy donor ones remains the best and often only treatment option for end-stage organ disease. Immunosuppressants have decreased the incidence of acute rejection, but long-term survival remains limited. The broad action of current immunosuppressive...
| Huvudupphovsmän: | , , , |
|---|---|
| Materialtyp: | Artikel |
| Språk: | English |
| Publicerad: |
Frontiers Media S.A.
2023-11-01
|
| Serie: | Frontiers in Immunology |
| Ämnen: | |
| Länkar: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1291649/full |